<DOC>
	<DOCNO>NCT01458535</DOCNO>
	<brief_summary>The purpose study evaluate efficacy , safety pharmacokinetics ABT-450/r give together ABT-267 without RBV treatment-naïve participant genotype 1 , 2 3 chronic HCV infection .</brief_summary>
	<brief_title>A Study Evaluate Paritaprevir With Ritonavir ( ABT-450/r ) When Given Together With Ombitasvir With Without Ribavirin ( RBV ) Treatment-Naïve Participants With Genotype 1 , 2 3 Chronic Hepatitis C Virus ( HCV )</brief_title>
	<detailed_description>This 2 sequential arm , combination treatment study arm contain 3 cohort : one HCV genotype 1 , 2 , 3 . The study consist 2 phase , treatment phase post-treatment phase . The treatment phase design explore antiviral activity , safety pharmacokinetics ABT-450/r dose combination ABT-267 without RBV 12 week . The post-treatment phase design monitor evaluate Sustained Virologic Response ( SVR ) 12 , SVR 24 , evolution persistence viral resistance ABT-267 ABT-450 HCV genotype 1- , 2- , 3-infected participant expose ABT-267 ABT-450/r . Arms 1 2 enrol sequentially .</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis C , Chronic</mesh_term>
	<mesh_term>Ribavirin</mesh_term>
	<mesh_term>Ritonavir</mesh_term>
	<criteria>Participants body mass index 18 &lt; 35 kg/m^2 . Females either postmenopausal least 2 year , surgically sterile , willing use least 2 effective form birth control . Males must surgically sterile agree use least 2 effective form birth control throughout course study . Participants condition general good health , HCV infection . Participants chronic HCV genotype 1 , 2 , 3 infection least 6 month , plasma HCV RNA &gt; 50,000 IU/mL , FibroTest score &lt; = 0.72 aspartate aminotransferase ( AST ) platelet ratio index &lt; = 2 , Fibroscan® result &lt; 9.6 kilopascal ( kPa ) , absence cirrhosis base liver biopsy . Positive drug screen Previous use antiHCV agent History cardiac disease History uncontrolled diabetes diabetes require insulin Abnormal laboratory result Females pregnant plan become pregnant within 6 month last dose study drug/RBV breastfeeding ; male whose partner pregnant would become pregnant within 6 month last dose study drug/RBV Positive test result hepatitis B surface antigen ( HBsAg ) antihuman immunodeficiency virus ( HIV ) antibody ( Ab ) . Negative HIV status confirm screening .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Genotype 1</keyword>
	<keyword>Genotype 2</keyword>
	<keyword>Genotype 3</keyword>
	<keyword>Hepatitis C Virus</keyword>
	<keyword>ABT-450/r</keyword>
	<keyword>Ribavirin</keyword>
	<keyword>ABT-267</keyword>
	<keyword>Ombitasvir</keyword>
	<keyword>Paritaprevir</keyword>
</DOC>